ESKAPE Pathogens in Bloodstream Infections: Dynamics of Antimicrobial Resistance from 2018 to 2024—A Single-Center Observational Study in Poland
Journal of Clinical Medicine · 30.09.2025 · 14 (19) · 6932
DOI: 10.3390/jcm14196932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.09.2025. Verfasst von Aneta Guzek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, Section of Microbiology, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Own funds of the Military Institute of Medicine - National Research Institute, Warsaw, Poland.
Abstract (Originalsprache)
Background/Objectives: Modern healthcare faces a growing burden of antimicrobial resistance, prominently driven by ESKAPE pathogens. These organisms—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.—are the leading causes of healthcare-associated infections, associated with limited therapeutic options and increased morbidity. Continuous surveillance is crucial for informing empirical therapy and guiding stewardship.
Methods
We perform a single-center, seven-year retrospective study (2018–2024) at a 1000-bed tertiary hospital in Warsaw, Poland. Bloodstream isolates of ESKAPE pathogens were identified according to the EUCAST guidelines. Data were analyzed by pathogen, ward, and year of isolation.
Results
From 2483 positive blood cultures, 3724 ESKAPE pathogens were recovered. S. aureus and K. pneumoniae predominated, particularly in the Intensive Care Unit and Hematology ward. Resistance analysis revealed persistently high vancomycin resistance in E. faecium, variable but notable methicillin resistance in S. aureus, and frequent ESBL production in K. pneumoniae with an alarming rise in carbapenemase-producing strains, including dual NDM + OXA-48 co-producers. A. baumannii exhibited near-universal multidrug resistance. P. aeruginosa demonstrated lower resistance rates with preserved colistin susceptibility, while Enterobacter spp. remained fully carbapenem-susceptible. Linezolid retained activity against E. faecium, while colistin remained effective against A. baumannii and P. aeruginosa. Modern β-lactam/β-lactamase inhibitor combinations were active against K. pneumoniae.
Conclusions
Our findings underscore the critical role of ESKAPE pathogens in bloodstream infections and highlight divergent resistance patterns across species. The emergence of carbapenemase-producing K. pneumoniae and the persistence of multidrug-resistant A. baumannii are of particular concern. Sustained surveillance, robust antimicrobial stewardship, and tailored infection control strategies remained essential to curb the evolving resistance threat in tertiary care settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Diagnostics, Section of Microbiology, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
- Department of Anesthesiology and Intensive Therapy, Military Institute of Aviation Medicine, 01-755 Warsaw, Poland.
- Department of Anesthesiology and Intensive Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
- Department of Laboratory Diagnostics, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
- Department of Epidemiology and Tropical Medicine, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
- Department of Public Health, Epidemiology and Vaccinology, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
ORCID-Profile: Aneta Guzek, Dariusz Tomaszewski, Zbigniew Rybicki, Wiesław Piechota, Katarzyna Mackiewicz, Anna Olczak-Pieńkowska
Förderung
- Own funds of the Military Institute of Medicine - National Research Institute, Warsaw, Poland
Zitieren
APA
Guzek, A., Tomaszewski, D., Rybicki, Z., Piechota, W., Mackiewicz, K., Konior, M., & Olczak-Pieńkowska, A. (2025). ESKAPE Pathogens in Bloodstream Infections: Dynamics of Antimicrobial Resistance from 2018 to 2024—A Single-Center Observational Study in Poland. Journal of Clinical Medicine, 14(19), 6932. https://doi.org/10.3390/jcm14196932
Vancouver
Guzek A, Tomaszewski D, Rybicki Z, Piechota W, Mackiewicz K, Konior M, et al. ESKAPE Pathogens in Bloodstream Infections: Dynamics of Antimicrobial Resistance from 2018 to 2024—A Single-Center Observational Study in Poland. Journal of Clinical Medicine. 2025;14(19):6932. doi:10.3390/jcm14196932
BibTeX
@article{Guzek2025,
author = {Guzek, Aneta and Tomaszewski, Dariusz and Rybicki, Zbigniew and Piechota, Wiesław and Mackiewicz, Katarzyna and Konior, Monika and Olczak-Pieńkowska, Anna},
title = {ESKAPE Pathogens in Bloodstream Infections: Dynamics of Antimicrobial Resistance from 2018 to 2024—A Single-Center Observational Study in Poland},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {19},
pages = {6932},
doi = {10.3390/jcm14196932}
}
EUVIMED